Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis

Five days following the 3rd cycle of nivolumab, a monoclonal antibody, which acts as immune checkpoint inhibitor against the programmed cell death protein-1, for metastatic lung adenocarcinoma, a 56-year-old woman presented at the hospital critically ill. On admission, she had severe diabetic ketoac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzoulis, Ploutarchos, Corbett, Richard W, Ponnampalam, Swarupini, Baker, Elly, Heaton, Daniel, Doulgeraki, Triada, Stebbing, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Unusual Effects of Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863245/
https://www.ncbi.nlm.nih.gov/pubmed/29576870
http://dx.doi.org/10.1530/EDM-18-0111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863245/
https://www.ncbi.nlm.nih.gov/pubmed/29576870
http://dx.doi.org/10.1530/EDM-18-0111

Ejemplares similares